Foamix Pharmaceuticals Ltd.

Foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological conditions.Through our proprietary technology platform, Foamix has developed a line of unique and innovative topical foam formulations.  This platform provides the versatility to develop new topical products for the possible treatment of dermatological and other conditions.  The potential advantages of foam include enhanced usability and compliance, improved tolerability, and targeted drug delivery.

Bank Name Foamix Pharmaceuticals Ltd.
Stock Exchange NASDAQ
Symbol FOMX
Sector Healthcare
Industry Specialty Chemicals
Country United States
World Region America
CEO Mr. David T. Domzalski
Employees 71
Registered Year 2003